{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:54:34Z","timestamp":1790553274088,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T00:00:00Z","timestamp":1122336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmo"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00417-005-0036-1","type":"journal-article","created":{"date-parts":[[2005,7,25]],"date-time":"2005-07-25T19:17:59Z","timestamp":1122319079000},"page":"205-209","source":"Crossref","is-referenced-by-count":43,"title":["Inhibitory effect of triamcinolone acetonide on corneal neovascularization"],"prefix":"10.1007","volume":"244","author":[{"given":"Masatoshi","family":"Murata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saburo","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,7,26]]},"reference":[{"key":"36_CR1","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/archopht.1990.01070120122041","volume":"108","author":"RL Avery","year":"1990","unstructured":"Avery RL, Connor TB, Farazdaghi M (1990) Systemic amiloride inhibits experimentally induced neovascularization. Arch Ophthalmol 108:1474\u20131478","journal-title":"Arch Ophthalmol"},{"key":"36_CR2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jcp.1041550315","volume":"155","author":"F Blei","year":"1993","unstructured":"Blei F, Wilson EL, Mignatti P (1993) Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155:568\u2013578","journal-title":"J Cell Physiol"},{"key":"36_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1442-9071.1998.tb01330.x","volume":"26","author":"JK Challa","year":"2000","unstructured":"Challa JK, Gillies MC, Penfold PL (2000) Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol 26:277\u2013281","journal-title":"Aust N Z J Ophthalmol"},{"key":"36_CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archopht.119.3.399","volume":"119","author":"TA Ciulla","year":"2001","unstructured":"Ciulla TA, Criswell MH, Danis RP (2001) Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 119:399\u2013404","journal-title":"Arch Ophthalmol"},{"key":"36_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0074-7696(08)62106-3","volume":"159","author":"GW Cockerill","year":"1995","unstructured":"Cockerill GW, Gamble JR, Vadas MA (1995) Angiogenesis: models and modulators. Int Rev Cytol 159:113\u2013160","journal-title":"Int Rev Cytol"},{"key":"36_CR6","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0161-6420(96)30383-7","volume":"103","author":"RP Danis","year":"1997","unstructured":"Danis RP, Bingaman DP, Yang Y (1997) Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103:2099\u20132104","journal-title":"Ophthalmology"},{"key":"36_CR7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","volume":"20","author":"RP Danis","year":"2000","unstructured":"Danis RP, Ciulla TA, Pratt LM (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20:244\u2013250","journal-title":"Retina"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archopht.1994.01090180111045","volume":"112","author":"K Dastgheib","year":"1994","unstructured":"Dastgheib K, Green WR (1994) Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol 112:813\u2013818","journal-title":"Arch Ophthalmol"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0002-9394(79)90245-9","volume":"87","author":"TA Deutsch","year":"1979","unstructured":"Deutsch TA, Hughes WF (1979) Suppressive effects of indomethacin on thermally induced neovascularization of rabbit corneas. Am J Ophthalmol 87:536\u2013540","journal-title":"Am J Ophthalmol"},{"key":"36_CR10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9394(14)77376-3","volume":"93","author":"RM Duffin","year":"1997","unstructured":"Duffin RM, Weissman BA, Glasser DB (1997) Flurbiprofen in the treatment of corneal neovascularization induced by contact lenses. Am J Ophthalmol 93:607\u2013611","journal-title":"Am J Ophthalmol"},{"key":"36_CR11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00000658-198709000-00016","volume":"206","author":"J Folkman","year":"1987","unstructured":"Folkman J, Ingber DE (1987) Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 206:374\u2013383","journal-title":"Ann Surg"},{"key":"36_CR12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1126\/science.2467380","volume":"243","author":"J Folkman","year":"1989","unstructured":"Folkman J, Weisz PB, Joullie MM (1989) Control of angiogenesis with synthetic heparin substitutes. Science 243:1490\u20131495","journal-title":"Science"},{"key":"36_CR13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","volume":"121","author":"MC Gillies","year":"2003","unstructured":"Gillies MC, Simpson JM, Luo W (2003) A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 121:667\u2013673","journal-title":"Arch Ophthalmol"},{"key":"36_CR14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnci\/52.2.413","volume":"52","author":"MA Gimbrone","year":"1974","unstructured":"Gimbrone MA, Cotran RS, Leapman SB (1974) Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 52:413\u2013427","journal-title":"J Natl Cancer Inst"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajo.2004.05.028","volume":"138","author":"M Inoue","year":"2004","unstructured":"Inoue M, Takeda K, Morita K (2004) Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection. Am J Ophthalmol 138:1046\u20131048","journal-title":"Am J Ophthalmol"},{"key":"36_CR16","first-page":"1217","volume":"120","author":"MS Ip","year":"2002","unstructured":"Ip MS, Kumar KS (2002) Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 120:1217\u20131219","journal-title":"Arch Ophthalmol"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archopht.1985.01050050100026","volume":"103","author":"T Ishibashi","year":"1985","unstructured":"Ishibashi T, Miki K, Sorgente N (1985) Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 103:708\u2013711","journal-title":"Arch Ophthalmol"},{"key":"36_CR18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","volume":"136","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF (2003) Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 136:384\u2013386","journal-title":"Am J Ophthalmol"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/eye.1990.86","volume":"4","author":"MC Killingsworth","year":"1990","unstructured":"Killingsworth MC, Sarks JP, Sarks SH (1990) Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 4:613\u2013621","journal-title":"Eye"},{"key":"36_CR20","first-page":"1929","volume":"37","author":"A Kvanta","year":"1996","unstructured":"Kvanta A, Algvere PV, Berglin L (1996) Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Investig Ophthalmol Vis Sci 37:1929\u20131934","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"36_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1442-9071.1996.tb01596.x","volume":"24","author":"MS Loughman","year":"1997","unstructured":"Loughman MS, Chatzistefanou K, Gonzalez EM (1997) Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor. Aust N Z J Ophthalmol 24:289\u2013295","journal-title":"Aust N Z J Ophthalmol"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF00947088","volume":"235","author":"M Murata","year":"1997","unstructured":"Murata M, Nakagawa M, Takahashi S (1997) Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas. Graefe Arch Clin Exp Ophthalmol 235:584\u2013586","journal-title":"Graefe Arch Clin Exp Ophthalmol"},{"key":"36_CR23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/jop.2000.16.383","volume":"16","author":"M Murata","year":"2000","unstructured":"Murata M , Kador PF, Sato S (2000) Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. J Ocular Pharmacol Ther 16:383\u2013391","journal-title":"J Ocular Pharmacol Ther"},{"key":"36_CR24","first-page":"1891","volume":"40","author":"H Oh","year":"1999","unstructured":"Oh H, Takagi H, Takagi C, Suzuma K, Otani A, Ishida K, Matsumura M, Ogura Y, Honda Y (1999) The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Investig Ophthalmol Vis Sci 40:1891\u20131898","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"36_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1442-9071.1995.tb00179.x","volume":"23","author":"PL Penfold","year":"1995","unstructured":"Penfold PL, Gyory JF, Hunyor AB (1995) Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust N Z J Ophthalmol 23:293\u2013298","journal-title":"Aust N Z J Ophthalmol"},{"key":"36_CR26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006982-200005000-00024","volume":"20","author":"GA Peyman","year":"2000","unstructured":"Peyman GA, Cheema R, Conway MD (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20:554\u2013555","journal-title":"Retina"},{"key":"36_CR27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843\u2013845","journal-title":"Nature"},{"key":"36_CR28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bjo.87.8.1010","volume":"87","author":"KH Sonoda","year":"2003","unstructured":"Sonoda KH, Enaida H, Ueno A (2003) Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol 87:1010\u20131014","journal-title":"Br J Ophthalmol"},{"key":"36_CR29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0142-9612(98)00233-6","volume":"19","author":"Y Tabata","year":"1998","unstructured":"Tabata Y, Yamada K, Miyamoto S (1998) Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 19:807\u2013815","journal-title":"Biomaterials"},{"key":"36_CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(93)90354-P","volume":"604","author":"JE Wolff","year":"1993","unstructured":"Wolff JE, Guerin C, Laterra J (1993) Dexamethasone reduces vascular density and plasminogen activator activity in 9\u00a0L rat brain tumors. Brain Res 604:79\u201385","journal-title":"Brain Res"},{"key":"36_CR31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000055582","volume":"32","author":"CF Yang","year":"2000","unstructured":"Yang CF, Yasukawa T, Kimura H (2000) Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel. Ophthalmic Res 32:19\u201324","journal-title":"Ophthalmic Res"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-005-0036-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-005-0036-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-005-0036-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:30:30Z","timestamp":1559071830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-005-0036-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,26]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s00417-005-0036-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,26]]}}}